Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Belgium France Spain
  • Study of Drug Combination for Advanced Cancer Patients with Known Molecular Profile – FINPROVE Study

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Finland
  • Study of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy

    Recruiting

    1 1 1 1
    Germany Poland Romania Spain Sweden
  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Austria Belgium France Germany Italy Poland +1
  • Study on the Safety and Effectiveness of [90Y]Y-PentixaTher in Patients with Recurrent or Resistant CNS Lymphoma

    Recruiting

    1 1 1 1
    Germany
  • Study on BI-1808 and Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Hungary Spain Sweden
  • Study of drug combination in patients with advanced cancer based on genomic profiling – ProTarget Danish nationwide trial

    Recruiting

    2 1 1 1
    Denmark
  • Study on the Safety and Effects of OBT076 and Balstilimab in Patients with Recurrent or Metastatic CD205-Positive Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Greece Spain
  • Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Greece +4
  • Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain